Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper

Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper

Most researchers support the important role of incretins, particularly glucagon-like peptide-1 in improving metabolic control in patients with type 2 diabetes after bariatric operations, mostly involving shunting. A positive effect of bariatric surgery for type 2 diabetes is known from numerous publ...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2012-06-01
Series:	Ожирение и метаболизм
Subjects:	morbid obesity type 2 diabetes bariatric surgery incretins
Online Access:	https://www.omet-endojournals.ru/jour/article/view/6539

Similar Items

Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones
by: Isabel Casimiro, et al.
Published: (2019-05-01)

The prevalence of zinc deficiency in morbidly obese patients before and after different types of bariatric surgery
by: Fahimeh Soheilipour, et al.
Published: (2021-05-01)

Peripheral polyneuropathy after bariatric surgery for morbid obesity
by: I-Ching Lin, et al.
Published: (2011-01-01)

Impact of bariatric surgery on type 2 diabetes in morbidly obese patients and its correlation with pre-operative prediction scores
by: Mehul Gupta, et al.
Published: (2021-01-01)

BARIATRIC SURGERIES AND CORRECTION OF METABOLIC DISORDERS IN PATIENTS WITH MORBID OBESITY
by: V. O. Khanov, et al.
Published: (2012-07-01)

Food tolerance, nutritional status and health-related quality of life of patients with morbid obesity after bariatric surgery in a public hospital in Malaysia
by: Tsen, Elina Poh Yue
Published: (2021)

Association between Depressed Mood and Morbid Obesity: Experience from a Bariatric Surgery Program
by: Vishal Farid Raza, et al.
Published: (2022-04-01)

Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus
by: Natalya S. Bordan, et al.
Published: (2017-08-01)

Glucose metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after Biliopancreatic bypass surgery in the modification of Hess-Marceau the early stages of postoperative monitoring
by: Ivan Ivanovich Dedov, et al.
Published: (2015-04-01)

Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients
by: Myung Jin Kim, et al.
Published: (2014-07-01)

Surgical Treatment of Morbid Obesity
by: Chang Min Lee, et al.
Published: (2017-06-01)

Pattern of liver function tests in morbidly obese Saudi patients undergoing bariatric surgery
by: Ahmad Al Akwaa, et al.
Published: (2011-01-01)

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
by: Joanna Michałowska, et al.
Published: (2021-01-01)

Evaluation of risk factors for bariatric surgery in elderly patients with morbid obesity
by: K. A. Anisimova, et al.
Published: (2022-05-01)

CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY
by: Fernando de BARROS, et al.
Published: (2016-12-01)

Effects of bariatric surgery on the level of hormones that regulate body weight. What is the basis of success?
by: Alina Yur'evna Babenko, et al.
Published: (2014-12-01)

Comparing bariatric surgery and medical therapy for obese adolescents with type 2 diabetes
by: Xinqiang Zhu, et al.
Published: (2023-10-01)

Bariatric Surgery Normalizes Protein Glycoxidation and Nitrosative Stress in Morbidly Obese Patients
by: Barbara Choromańska, et al.
Published: (2020-11-01)

Variables Associated with Short-Term Weight Loss in a Cohort of Patients with Morbid Obesity According to Age and Three Types of Bariatric Surgery
by: Maria D. Alvarez-Bermudez, et al.
Published: (2020-11-01)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01)

Bariatric surgery: impact on sexuality of the obese person
by: Maria Luiza Lobato Mariano, et al.

Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment
by: Kok-Hou Lok, et al.
Published: (2022-06-01)

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass
by: Laura Hernández-Montoliu, et al.
Published: (2023-10-01)

The cluster analysis of patients with morbid obesity in bariatric and metabolic surgery
by: S. E. Voskanyan, et al.
Published: (2022-09-01)

Case of insulinoma detected in a patient after bariatric operation for morbid obesity
by: Ekaterina S. Maloletkina, et al.
Published: (2019-06-01)

Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
by: I I Larina, et al.
Published: (2018-10-01)

Use of bariatric surgery in patients with type 2 diabetes: help to the practitioner
by: Ekaterina V. Ershova, et al.
Published: (2016-03-01)

Predictors of diabetes remission after bariatric surgery in Asia
by: Wei-Jei Lee, et al.
Published: (2012-04-01)

Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery
by: Ji Yeon Park
Published: (2018-12-01)

Assessment of dietary intake and biochemical parameters of morbidly obese Omani patients who are candidates for bariatric surgery
by: Juhaina Al-Maskari, et al.
Published: (2024-02-01)

Effect of Weight Reduction Following Bariatric Surgery on Serum Visfatin and Adiponectin Levels in Morbidly Obese Subjects
by: Mohammad Javad Hosseinzadeh-Attar, et al.
Published: (2013-04-01)

Bariatric surgery and diabetes
by: Andrew Collier
Published: (2012-01-01)

Innovations in the treatment of type 2 diabetes mellitus: use of incretins
by: Ivan Ivanovich Dedov, et al.
Published: (2010-10-01)

Combined Airway and Bariatric Surgery (CABS) for Obstructive Sleep Apnea Patients with Morbid Obesity: A Comprehensive Alternative Preliminary Study
by: Chia-Chen Lin, et al.
Published: (2022-11-01)

The comparison of pulmonary functions After the bariatric surgery In Morbid obeses Versus Super Obeses
by: Burcu Yormaz, et al.
Published: (2018-10-01)

Association of genetic variants of the incretin-related genes with quantitative traits and occurrence of type 2 diabetes in Japanese
by: Mayumi Enya, et al.
Published: (2014-01-01)

A Longitudinal Study of the Antioxidant Barrier and Oxidative Stress in Morbidly Obese Patients after Bariatric Surgery. Does the Metabolic Syndrome Affect the Redox Homeostasis of Obese People?
by: Barbara Choromańska, et al.
Published: (2020-04-01)

Ileal transposition in surgical treatment for type 2 diabetes mellitus
by: Oleg Viktorovich Kornyushin, et al.
Published: (2015-03-01)

NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity
by: Iurii Stafeev, et al.
Published: (2021-12-01)

Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial
by: Faranak Rokhtabnak, et al.
Published: (2023-11-01)